Telemetric monitoring of blood pressure treatment in patients with inadequately treated hypertensio

Phase 3

• Conditions: I10.0; I10.1; I10.9; O10.0; Pre-existing essential hypertension complicating pregnancy, childbirth and the puerperium

• Registration Number: DRKS00021471
• Lead Sponsor: ephrologisches Zentrum Göttingen

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2017-08-01
• Study Start: 2020-04-22
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Age> 18 years <80 years
- 24-hour RR mean (ABDM)> 130/80 mmHg
- A written declaration of consent is available

Exclusion Criteria

- insufficient psychological resilience (psychiatric treatment)
- renal artery stenosis
- Pregnancy
- Pheochromocytoma
- malignant hypertension
- acute kidney failure
- terminal renal failure (creatinine clearance <20 ml / min)
- cerebrovascular events
- hypertensive encephalopathy
- Heart attack in the past 6 months
- unstable AP
- untreated diabetes mellitus
- untreated hyper- or hypothyroidism
- clinically important hepatic, gastrointestinal, haematological, pulmonary or neurological disorders
- K + <3.5 mmol / l or> 5.5 mmol / l
- Transaminase increase
- Coagulation disorders
- Steroids in medication
- Alcohol or medication abuse
- Hypersensitivity or contraindications for the AT1 receptor blockers used

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Blood pressure target values ??in 24-hour ABDM after telemonioring intervention over 3 months.

Secondary Outcome Measures

Name	Time	Method
Telemetric blood pressure curve under drug titration.